project id: TCGA-BLCA; case submitter id: TCGA-CF-A27C; selected normal wgs: true; source center: 23; state: released; normal tumor genotype snp match: Yes; spectrophotometer method: UV Spec; age at index: 52; days to birth: -19270; ethnicity: not hispanic or latino; gender: male; race: asian; vital status: Alive; year of birth: 1959; age at diagnosis: 19270; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 425.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8130/3; primary diagnosis: Papillary transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Not Reported; is ffpe: false; days to collection: 79; days to sample procurement: 0; initial weight: 430.0; portion submitter id: TCGA-CF-A27C-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 4.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0; percent stromal cells: 12.0; percent tumor cells: 84.0; percent tumor nuclei: 95.0;